期刊文献+

左归丸加减治疗再生障碍性贫血 被引量:1

原文传递
导出
摘要 目的:探讨再生障碍性贫血患者采用左归丸治疗的临床效果。方法:笔者于2013年5月-2014年1月收取临床病例资料,将其进行分组治疗,其中治疗组59例采用西医综合疗法加左归丸治疗,对照组58例采用左归丸治疗,对比两组患者治疗效果。结果:治疗组治疗总有效率为94.9%;对照组治疗总有效率为82.7%。治疗组患者临床治疗效果明显优于对照组,有统计学意义(P<0.05)。两组不良反应情况比较无统计学意义(P>0.05)。结论:左归丸加减联合西药治疗再生障碍性贫血协同作用明显,疗效显著,且可减轻药物毒副作用,提高患者生活质量,值得推广。
作者 许海平
机构地区 瑞金市人民医院
出处 《黑龙江中医药》 2015年第2期45-46,共2页 Heilongjiang Journal of Traditional Chinese Medicine
  • 相关文献

参考文献5

二级参考文献33

  • 1鹿全意,牛小青,郭勇,张鹏,曾晓新,付肖凡,周娟娟.G-CSF动员的异基因外周血干细胞和骨髓联合移植治疗白血病[J].中国实验血液学杂志,2005,13(2):326-328. 被引量:7
  • 2鹿全意,郭勇,蔡玉贤,牛小青,张鹏,陈小燕.父母为供者的异基因外周血干细胞移植治疗白血病六例[J].中华器官移植杂志,2006,27(1):56-57. 被引量:1
  • 3Kurre P, Johnson FL, Deeg HJ, Diagnosis and treatment of children with Aplastic Anemia. Pediatr Blood Cancer, 2005:45 (6) : 770-780.
  • 4Bacigalupo A. Aplastic Anemia: Pathogenesis and treatment. American Society of Haematology Education program book, 2007: 23-28.
  • 5Gluckman E, Devergie A, Poros A,et al. Results of Immunosuppressive in 170 cases of severe Aplastic Anemia: Report of the European group of Bone Marrow Transplant (EBMT). Br J Haematol, 1982,51(4):541-550.
  • 6Camitta BM, Thomas ED, Nathan DG,et al. Severe Aplastic Anemia. A prospective study of the effect of early marrow transplantation on Acute mortality. Blood, 1976,48(1):63-70.
  • 7Solomou EE, Rezvani K, Mielke S, et al. Deficient CD4+, CD25 +, foxp3 + T Regulatory Cells in Acquired Aplastic Anemia. Blood, 2007,110(5) :1603-1606.
  • 8Young NS, Calado RT, Scheinberg P. Current concepts in the pathophysiology and treatment of Aplastic Anemia. Blood, 2006, 108(8) :2509-2519.
  • 9Solomou EE, Keyvanfar K, Young NS. T-bet, a Th1 transcription factor, is up-regulated in T cells from patients with aplastic anemia. Blood, 2006,107(10) :3983-3991.
  • 10Locasciulli A, Oneto R, Bacigalupo A, et al. Severe Aplastic Anemia working party of the European Blood and Marrow Transplant Group. Outcome of patients with Acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade. A report from the European Group for Blood and Marrow Transplantation (EBMT). Haematologica, 2007,92(1) :11-18.

共引文献19

同被引文献14

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部